SMITH DAVID V (Executive Vice President & CFO) exercised options at FIVE PRIME THERAPEUTICS, INC.
Option exercise — a mechanical event triggered by vesting or expiry. Not a discretionary conviction trade.
M · 1 exercise
Filed: 11/13/2020ACC: 0001209191-20-058241
Officer· Executive Vice President & CFO
Since Nov 2018
-10.91K
Net shares
Net seller
$196.3K
Total sold
0
Open market trades
0B · 0S
3
Total transactions
22K acquired · 32.91K disposed
Non-Derivative Transactions2
Common Stock
Direct
Shares
+22K
Price / share
—
Trade value
—
% of position
34.7%
11/11/2020
63.39K→85.39K
Common Stock
Direct
Shares
−10.91K
Price / share
$18.00
Trade value
$196.34K
% of position
12.8%
11/11/2020
85.39K→74.48K
Total
Net shares
+11.09K
Net value
-$196.34K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 11/11/2020 | M · Option Exercise | +22K | — | — | 34.7% | 63.39K | 85.39K |
| Common Stock Direct | 11/11/2020 | F · Tax Withholding | −10.91K | $18.00 | $196.34K | 12.8% | 85.39K | 74.48K |
| Total | +11.09K | -$196.34K | ||||||
Derivative Transactions1
Performance-Based Restricted Common Stock
Direct
Converts to
Common Stock
22K shares
Shares
−22K
Strike price
Held after
22K
Exercisable
—
11/11/2020
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Performance-Based Restricted Common Stock Direct | Common Stock22K shares | 11/11/2020 | M · Option Exercise | −22K | — | 22K |